A246

SLS BIO Co., Ltd Stock Price

KOSDAQ:A246250 Community·₩26.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A246250 Share Price Performance

₩1,969.00
387.00 (24.46%)
₩1,969.00
387.00 (24.46%)
Price ₩1,969.00

A246250 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

SLS BIO Co., Ltd Key Details

₩7.3b

Revenue

₩6.1b

Cost of Revenue

₩1.2b

Gross Profit

₩2.7b

Other Expenses

-₩1.5b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-112.57
15.81%
-21.07%
0%
View Full Analysis

About A246250

Founded
2007
Employees
n/a
CEO
Lee Young Tae
WebsiteView website
www.slabs.co.kr

SLS BIO Co., Ltd develops diagnostic technologies in South Korea. It offers pharmaceuticals quality control testing services, including pharmaceutical equivalence study, raw materials/finished drugs test, and other analysis testing services; and efficacy evaluation services, such as immune function-based efficacy evaluation and pharmacokinetics and toxicokinetics analysis services. In addition, it provides diagnostic kits comprising rapid allergy test, rapid bovine pregnancy diagnosis, and horse individual forensic kits, as well as nano-bio technologies. The company was formerly known as Specialty Lab Solution Co., Ltd. and changed its name to SLS BIO Co., Ltd in July 2017. SLS BIO Co., Ltd was founded in 2007 and is based in Suwon-si, South Korea.

Recent A246250 News & Updates

Recent updates

No updates